1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co.,Ltd.

6615.TWO
Sofiva Genomics Co.,Ltd.TW flagTaipei Exchange
36.75
TWD
-0.20
- -
793.56MMarket Cap

Total Valuation

Sofiva Genomics Co.,Ltd. carries a market capitalization of 793.56M, placing it among publicly traded companies globally. Its enterprise value stands at 569.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap793.56M
Enterprise Value569.53M

Share Statistics

Sofiva Genomics Co.,Ltd. currently has 21.59M shares outstanding.

Shares Outstanding21.59M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Sofiva Genomics Co.,Ltd. trades at a trailing price-to-earnings ratio of 226.58. The price-to-sales ratio is 1.71, and the price-to-book ratio stands at 2.64.

PE Ratio226.58
PS Ratio1.71
PB Ratio2.64
P/TBV Ratio1.06
P/FCF Ratio28.01
P/OCF Ratio42.88

Enterprise Valuation

EV / Sales1.48
EV / EBITDAN/A
EV / EBITN/A
EV / FCF23.33

Financial Position

Sofiva Genomics Co.,Ltd. maintains a current ratio of 3.33, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.65, indicating elevated leverage, while an interest coverage ratio of -39.82 demonstrates limited ability to service its debt obligations.

Current Ratio3.33
Quick Ratio1.76
Debt / Equity5.65
Debt / EBITDA-1.05
Interest Coverage-39.82

Financial Efficiency

Return on Equity (ROE)-3.63
Return on Assets (ROA)-1.25
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-3.01
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover7.05

Taxes

Over the trailing twelve months, Sofiva Genomics Co.,Ltd. has paid 551,000.00 in income taxes, reflecting an effective tax rate of 140.93.

Income Tax551,000.00
Effective Tax Rate140.93

Stock Price Statistics

Sofiva Genomics Co.,Ltd.'s stock has gained approximately 11.36364% over the past 52 weeks. The 50-day moving average sits at 33.99, while the 200-day moving average is 32.70.

Beta (5Y)N/A
52-Week Price Change11.36364%
50-Day Moving Average33.99
200-Day Moving Average32.70
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Sofiva Genomics Co.,Ltd. generated 385.71M in revenue and converted that into -9.36M in net income, yielding earnings per share of -0.41. EBITDA reached -33.73M, while operating income came in at -33.73M.

Revenue385.71M
Gross Profit99.13M
Operating Income-33.73M
Pretax Income-8.30M
Net Income-9.36M
EBITDA-33.73M
EBIT-33.73M
Earnings Per Share (EPS)-0.41

Balance Sheet

Sofiva Genomics Co.,Ltd. holds 124.71M in cash and equivalents against 35.53M in total debt, resulting in a net debt position of -90.61M. Total book value stands at 249.13M, with working capital of 165.30M providing operational flexibility.

Cash & Cash Equivalents124.71M
Total Debt35.53M
Net Debt-90.61M
Equity (Book Value)249.13M
Book Value Per Share11.41
Working Capital165.30M

Cash Flow

Sofiva Genomics Co.,Ltd. produced 15.36M in operating cash flow over the past twelve months. After subtracting -8.15M in capital expenditures, free cash flow totaled 7.20M - equivalent to 0.33 per share.

Operating Cash Flow15.36M
Capital Expenditures-8.15M
Free Cash Flow7.20M
FCF Per Share0.33

Margins

Sofiva Genomics Co.,Ltd. operates with a gross margin of 25.70, reflecting its pricing power and cost economics. The operating margin of -8.74 and net profit margin of -2.43 provide insight into operational efficiency.

Gross Margin25.70
Operating Margin-8.74
Pretax Margin-2.15
Profit Margin-2.43
EBITDA Margin-8.74

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield3.38
FCF Yield3.57

Scores

Sofiva Genomics Co.,Ltd. posts an Altman Z-Score of 4.84, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score4.84